Clinical Trials Sponsored by Adherex Technologies, Inc

Total 547 results

Adherex Technologies, Inc.

Unknown

Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer

Metastatic Breast Cancer

United States, Russian Federation
Adherex Technologies, Inc.

Completed

A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan

Neoplasms

United States
Adherex Technologies, Inc.

Completed

Study of ADH-1 Given Intravenously to Patients With Solid Tumors

Neoplasms

Italy, Switzerland
Adherex Technologies, Inc.

Terminated

A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan, Singapore, United States
Adherex Technologies, Inc.

Suspended

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

Neoplasms

United States
Adherex Technologies, Inc.

Terminated

A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors

Neoplasms

United States
Adherex Technologies, Inc.

Completed

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Neoplasms

United States, Canada
Adherex Technologies, Inc.

Completed

A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

Neoplasms

United States
Adherex Technologies, Inc.
US Oncology Research

Completed

A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine

Neoplasms

United States
University of Nebraska
National Cancer Institute (NCI); Adherex Technologies, Inc.

Completed

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

Pancreatic Adenocarcinoma | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IVA Pancreatic Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gallbladder Cancer | Stage IIIB Gallbladder Cancer | Stage IVA Gallbladder Cancer | Stage IVB Gallbladder Cancer | Gallbladder Adenocarcinoma and other conditions

United States
Athenex, Inc.

Withdrawn

Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor
Athenex, Inc.

Unknown

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

Solid Tumor

United States
Athenex, Inc.

Completed

Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies

Advance Malignancies

United States
Athenex, Inc.

Completed

Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis

Actinic Keratosis

United States
Athenex, Inc.

Terminated

The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol

Solid Tumor, Adult

United Kingdom
Athenex, Inc.

Completed

A Study of Oraxol in Subjects With Cutaneous Angiosarcoma

Angiosarcoma of Skin

United States, United Kingdom, Taiwan, Hong Kong
Athenex, Inc.

Completed

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Bone-Metastatic, Castration-Resistant Prostate Cancer

United States
Athenex, Inc.

Completed

Evaluation of KX2-391 in Patients With Advanced Malignancies

Lymphoma | Solid Tumors

United States
Athenex, Inc.

Recruiting

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies (ANCHOR2)

B-cell Lymphoma | CLL/SLL | ALL, Childhood | DLBCL - Diffuse Large B Cell Lymphoma | B-cell Leukemia | NHL, Relapsed, Adult | ALL, Adult B Cell

United States
Athenex, Inc.

Recruiting

A Phase I Open-label Study for Subjects With Advanced Malignancies (PT01)

Advanced Solid Malignancies

United States
Athenex, Inc.

Terminated

Evaluate Eribulin ORA in Subjects With Solid Tumors

Solid Tumor

United States
Athenex, Inc.

Completed

Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer

Metastatic Breast Cancer

Argentina, Chile, Colombia, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Panama, Peru
Athenex, Inc.

Completed

A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies

Solid Tumor

United States
Athenex, Inc.

Active, not recruiting

Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers

Gastric Cancer | Esophageal Cancer | Gastro-esophageal Cancer

Taiwan, United States
Athenex, Inc.

Completed

Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies

Solid Tumor

United States, United Kingdom
Athenex, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies

Solid Tumor

United States
Athenex, Inc.

Completed

A PK Study of Oraxol in Breast Cancer Patients

Breastcancer

China
PharmaEssentia
Athenex, Inc.

Completed

KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis

Psoriasis
Athenex, Inc.
PharmaEssentia

Completed

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

Breastcancer

Taiwan
Athenex, Inc.
PharmaEssentia

Terminated

An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007

Breastcancer

Taiwan
Kinex Pharmaceuticals Inc.

Completed

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Acute Myelogenous Leukemia

United States
Athenex, Inc.
TKL Research, Inc.

Completed

Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis

Actinic Keratoses

United States
Almirall, S.A.
Athenex, Inc.

Completed

Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp

Actinic Keratosis

United States
Almirall, S.A.
Athenex, Inc.

Completed

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp (AK003)

Actinic Keratoses

United States
Almirall, S.A.
Athenex, Inc.

Completed

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)

Actinic Keratosis

United States
Neonc Technologies, Inc.

Not yet recruiting

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

High Grade Glioma | Pineocytoma | Diffuse Midline Glioma, H3 K27M-Mutant | Spinal Cord Tumor | Pediatric Tumor of CNS | Pediatric Tumor of Brain | Pediatric Tumor of Brain Stem | Choroid Plexus Carcinoma, Childhood
NovaResp Technologies Inc

Not yet recruiting

The Comfort of Proactive Sleep Apnea Therapy

Obstructive Sleep Apnea | Sleep Apnea
ROM Technologies, INC

Recruiting

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

Myocardial Infarction | Heart Failure | Coronary Artery Bypass | Stable Angina | Cardiac Rehabilitation | Valve Disease, Heart | Percutaneous Transluminal Coronary Angioplasty | Stent

United States
EnCompass Technologies, Inc.

Recruiting

Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Aortic Stenosis

Georgia
Palatin Technologies, Inc

Recruiting

A Phase 3, Multi-Center Study Evaluating PL9643 in Patients With Dry Eye (MELODY-1)

Dry Eye | Dry Eye Syndromes

United States
CellSight Technologies, Inc.

Recruiting

Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

United States
ROM Technologies, INC

Recruiting

ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral Total Knee Arthroplasty (TKA)

Joint Pain | Knee Osteoarthritis | Osteoarthritis, Knee | Osteo Arthritis Knee | Knee Arthritis | Knee Pain Chronic | Knee Disease

United States
NovaResp Technologies Inc

Completed

Prevention of Airway Obstruction Events

Sleep Apnea, Mixed Central and Obstructive

Canada
Elemind Technologies, Inc.

Completed

Sounds Locked to ElectroEncephalogram Phase For the Acceleration of Sleep Onset Time (SLEEPFAST)

Sleep | Sleep Disturbance

United States
Exciton Technologies Inc.

Completed

EPC Silver Wound Gel (EPC-123) Feasibility Study in the Management of Mildly Infected Diabetic Foot Ulcers

Diabetic Foot Ulcer | Diabetic Foot Infection | Non-healing Diabetic Foot Ulcer

Canada
InterShunt Technologies, Inc.

Active, not recruiting

Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure (EASE HF)

Heart Failure

Georgia
BioSig Technologies, Inc.

Completed

Redo AF Sub Study (of the Pure EP 2.0 Main Study)

Atrial Fibrillation Recurrent

United States
Intezyne Technologies, Inc.

Terminated

Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer

Neoplasms | Cancer | Tumors | Refractory Solid Tumors | Recurrent Solid Tumors

United States
Intuor Technologies, Inc.

Unknown

Cross Linking Corneal Biomechanical Evaluation of CATS Tonometer Prism

Keratoconus

United States
KLOX Technologies Inc.

Completed

Evaluation of the Safety and Efficacy of FBPM10 System in the Treatment of Post-surgical Wounds

Post-surgical Wounds

Canada

Clinical Trials Sponsored by Adherex Technologies, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations